Katarzyna Stachowicz

Has grant

Assistant professor

Maj Institute of Pharmacology Polish Academy of Sciences

Poland

Research Interests

Explore related searches

Professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Katarzyna Stachowicz is an Assistant Professor at the Maj Institute of Pharmacology, Polish Academy of Sciences in Krakow, Poland. Her research focuses on the role of neurotransmitters in central nervous system disorders, particularly in relation to mood and cognitive functions. Recent publications include studies on vanadium, the pharmacotherapy of depression, and interactions between metabotropic glutamate and cannabinoid receptors.

Recent Grants

Grant: Close

Involvement of cyclooxygenase 2 in antidepressant-like effects of metabotropic glutamatergic receptors group I.

Open Date:

Close Date:

Articles (20)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (4)

Patrycja Pańczyszyn-Trzewik

medical college of university of rzeszow

POLAND

View details

Agata Faron-Górecka

Maj Institute of Pharmacology Polish Academy of Sciences

POLAND

View details

Gabriel Nowak

Professor and Head of Department

Uniwersytet Jagiellonski Collegium Medicum

POLAND

View details

Magdalena Sowa-Kucma

Associate professor

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Katarzyna Stachowicz

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (20)

Vanadium - good or bad - The role of vanadium in the central nervous system disorders, potential therapeutic targets and its toxicity.

Special Issue: Molecular Research on Depression.

Time-dependent dual mode of action of COX-2 inhibition on mouse serum corticosterone levels

Repeated Sulforaphane Treatment Reverses Depressive-like Behavior and Exerts Antioxidant Effects in the Olfactory Bulbectomy Model in Mice

Cyclooxygenase-2 inhibition affects the ratio of GluN2A/GluN2B receptor subunits through interaction with mGluR5 in the mouse brain

Evidence for functional interaction between the CB1 and the mGlu7 receptors mediated signaling in modulation of anxiety behavior and cognition.

Special issue: Glutamate- physiology, pathology, therapy.

Interactions between metabotropic glutamate and CB1 receptors: implications for mood, cognition, and synaptic signaling based on data from mGluR and CB1R-targeting drugs.

Editorial: The pharmacotherapy of depression-searching for new mechanisms and drug interactions. Basic and clinical research, volume II.

Regulation of COX-2 expression by selected trace elements and heavy metals: Health implications, and changes in neuronal plasticity. A review

Changes in working memory induced by lipopolysaccharide administration in mice are associated with metabotropic glutamate receptors 5 and contrast with changes induced by cyclooxygenase-2: Involvement of postsynaptic density protein 95 and down syndrome cell adhesion molecule

Molecular Research on Mental Disorders

Physicochemical Principles of Adhesion Mechanisms in the Brain

The role of polyunsaturated fatty acids in neuronal signaling in depression and cognitive processes

The Importance of α-Klotho in Depression and Cognitive Impairment and Its Connection to Glutamate Neurotransmission—An Up-to-Date Review

Cyclooxygenase-2 inhibition affects the expression of down syndrome cell adhesion molecule via interaction with metabotropic glutamate receptor 5

The treatment of depression — searching for new ideas

Is PSD-95 entangled in the side effects of antidepressants?

Editorial: The pharmacotherapy of depression—searching for new mechanisms and drug interactions basic and clinical research

Application potential of modulation of cyclooxygenase-2 activity: a cognitive approach

Collaborators (4)

Patrycja Pańczyszyn-Trzewik

Agata Faron-Górecka

Gabriel Nowak

Magdalena Sowa-Kucma

Make your next move.